IP Library Granted Patent US 10,856,566
Granted Patent B2
US 10,856,566 · App. 15/549,063 · Granted Dec 8, 2020

Co-Q10, krill oil and vitamin D

Inventors: Ed Derohanes (Salt Lake City, UT); Kenneth Rayl (Salt Lake City, UT); Michal Siwek (Salt Lake City, UT); John Williams (Salt Lake City, UT)
Assignee: RB HEALTH (US) LLC
A23L33/155A23L29/06A23L29/10A23L33/10A23L33/115A23L33/12A23V2002/00A23V2200/326
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,856,566
App. No.
15/549,063
Granted
Dec 8, 2020
Kind
B2
Abstract

Embodiments of the invention are related generally to compositions comprising Co-Q10, a source of omega-3 fatty acids, and vitamin D, and methods of making thereof. In particular, the invention relates to stable compositions comprising Co-Q10, krill oil, vitamin D, and an antioxidant suitable for use as dietary supplements, and methods of making thereof. The compositions may further comprise an emulsifier to impart stability to the compositions.

Claims (19)

1. A dietary supplement composition consisting of:

Co-Q10 in an amount of at least about 5% to about 40% by weight based on the total weight of the composition;

about 25 IU to about 800 IU of vitamin D3;

krill oil in an amount of at least about 20% to about 90% by weight based on the total weight of the composition;

an antioxidant;

an emulsifier; and

one or more of a second vitamin, a flavoring agent, a coloring agent, and a sweetener,

wherein the antioxidant is ascorbic acid present in an amount sufficient to convert at least a portion of the amount of Co-Q10 to Co-QH,

wherein the emulsifier is polysorbate, and

wherein the composition is stable for at least four weeks at 40° C. and 75% relative humidity.

2. The composition of claim 1 prepared by a process comprising:

combining the Co-Q10, the antioxidant, the emulsifier, and to form a first mixture:

combining the vitamin D and the krill oil to form a second mixture;

combining the first mixture with the second mixture to form a third mixture; and

encapsulating the third mixture.

3. The composition of claim 1 , wherein the composition is in a form selected from the group consisting of a capsule, tablet, powder, chewable tablet, sublingual tablet, and sublingual drop.

4. The composition of claim 1 , wherein the composition is in the form of a capsule; and

wherein the capsule is a softgel.

5. The composition of claim 1 , wherein the flavoring agent comprises ethyl vanillin.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2019
From: RECKITT BENCKISER LLC
To: RB HEALTH (US) LLC
Reel/Frame 049451/0056 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2017
From: WILLIAMS, JOHN
To: RECKITT BENCKISER LLC
Reel/Frame 044050/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2017
From: SIWEK, MICHAL; DEROHANES, ED; RAYL, KENNETH
To: RECKITT BENCKISER LLC
Reel/Frame 043440/0611 →
Priority Claims (1)
GB 1505938.9 · Apr 8, 2015 · national
Continuity (2)
Provisional Application 62121786 · Feb 27, 2015
Related Publication 20180084813A1 · Mar 29, 2018